Literature DB >> 29143414

Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease.

Alessandro Tessitore1,2, Antonio Russo1,2, Rosa De Micco1,2, Michele Fratello1,3, Giuseppina Caiazzo1,2, Alfonso Giordano1,2, Mario Cirillo1,4, Gioacchino Tedeschi1,2, Fabrizio Esposito3.   

Abstract

BACKGROUND: Despite its clinical relevance, the pathophysiology of pain in Parkinson's disease (PD) is still largely unknown, and both central and peripheral mechanisms have been invoked.
OBJECTIVES: To investigate whether central pain processing is altered in "drug-naive" pain-free PD (dnPD) patients.
METHODS: Using event-related functional MRI (fMRI), functional response to forearm heat stimulation (FHS) at two different intensities (41°C and 53°C) was investigated in 20 pain-free dnPD patients, compared with 18 healthy controls (HCs). Secondary analyses were performed to evaluate associations between BOLD signal changes and PD clinical features and behavioral responses.
RESULTS: During low-innocuous FHS (41°C), no activation differences were found between dnPD patients and HCs. During high-noxious FHS (53°C) a significantly increased activation in the left somatosensory cortex, left cerebellum, and right low pons was observed in dnPD patients compared to HCs. In the latter experimental condition, fMRI BOLD signal changes in the right low pons (p < .0001; R = -0.8) and in the cerebellum (p = .004; R = -0.7) were negatively correlated with pain intensity ratings only in dnPD patients. No statistically significant difference in experimental pain perception was detected between dnPD patients and HCs.
CONCLUSIONS: Our findings suggest that a functional remodulation of pain processing pathways occurs even in the absence of clinically overt pain symptoms in dnPD patients. These mechanisms may eventually become dysfunctional over time, contributing to the emergence of pain symptoms in more advanced PD stages. The comprehension of pain-related mechanisms may improve the clinical approach and therapeutic management of this disabling nonmotor symptom.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Parkinson's disease; drug-naïve; functional MRI; pain

Mesh:

Substances:

Year:  2017        PMID: 29143414      PMCID: PMC6866276          DOI: 10.1002/hbm.23892

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  62 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  The Frontal Assessment Battery (FAB): normative values in an Italian population sample.

Authors:  I Appollonio; M Leone; V Isella; F Piamarta; T Consoli; M L Villa; E Forapani; A Russo; P Nichelli
Journal:  Neurol Sci       Date:  2005-06       Impact factor: 3.307

3.  Anatomical and functional correlates of persistent pain in Parkinson's disease.

Authors:  Andrea Polli; Luca Weis; Roberta Biundo; Michael Thacker; Andrea Turolla; Kostantinos Koutsikos; K Ray Chaudhuri; Angelo Antonini
Journal:  Mov Disord       Date:  2016-10-05       Impact factor: 10.338

4.  The effect of duloxetine on primary pain symptoms in Parkinson disease.

Authors:  Ruth Djaldetti; Shlomit Yust-Katz; Vadim Kolianov; Eldad Melamed; Ron Dabby
Journal:  Clin Neuropharmacol       Date:  2007 Jul-Aug       Impact factor: 1.592

5.  Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials.

Authors:  Michele Tinazzi; Claudia Del Vesco; Giovanni Defazio; Emiliana Fincati; Nicola Smania; Giuseppe Moretto; Antonio Fiaschi; Domenica Le Pera; Massimiliano Valeriani
Journal:  Pain       Date:  2007-08-31       Impact factor: 6.961

Review 6.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

7.  Mechanical allodynia in neuropathic pain. Where are the brain representations located? A positron emission tomography (PET) study.

Authors:  R Peyron; I Faillenot; F B Pomares; D Le Bars; L Garcia-Larrea; B Laurent
Journal:  Eur J Pain       Date:  2013-03-27       Impact factor: 3.931

8.  The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

Authors:  Paolo Barone; Angelo Antonini; Carlo Colosimo; Roberto Marconi; Letterio Morgante; Tania P Avarello; Eugenio Bottacchi; Antonino Cannas; Gabriella Ceravolo; Roberto Ceravolo; Giulio Cicarelli; Roberto M Gaglio; Rosa M Giglia; Francesco Iemolo; Michela Manfredi; Giuseppe Meco; Alessandra Nicoletti; Massimo Pederzoli; Alfredo Petrone; Antonio Pisani; Francesco E Pontieri; Rocco Quatrale; Silvia Ramat; Rosanna Scala; Giuseppe Volpe; Salvatore Zappulla; Anna Rita Bentivoglio; Fabrizio Stocchi; Giorgio Trianni; Paolo Del Dotto
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

Review 9.  Pain assessment: global use of the Brief Pain Inventory.

Authors:  C S Cleeland; K M Ryan
Journal:  Ann Acad Med Singapore       Date:  1994-03       Impact factor: 2.473

10.  Emotional modulation of experimental pain: a source imaging study of laser evoked potentials.

Authors:  Andrej Stancak; Nicholas Fallon
Journal:  Front Hum Neurosci       Date:  2013-09-17       Impact factor: 3.169

View more
  5 in total

1.  Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease.

Authors:  Alessandro Tessitore; Antonio Russo; Rosa De Micco; Michele Fratello; Giuseppina Caiazzo; Alfonso Giordano; Mario Cirillo; Gioacchino Tedeschi; Fabrizio Esposito
Journal:  Hum Brain Mapp       Date:  2017-11-15       Impact factor: 5.038

Review 2.  Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson's Disease.

Authors:  Tino Prell
Journal:  Front Neurol       Date:  2018-03-12       Impact factor: 4.003

3.  A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey.

Authors:  He-Yang You; Lei Wu; Hai-Ting Yang; Chen Yang; Xiao-Ling Ding
Journal:  Pain Res Manag       Date:  2019-01-22       Impact factor: 3.037

4.  Pain Assessment in Chinese Parkinson's Disease Patients Using King's Parkinson's Disease Pain Scale.

Authors:  Liang Gao; Weiling Huang; Laisheng Cai; Yufen Peng
Journal:  J Pain Res       Date:  2022-03-10       Impact factor: 3.133

5.  Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease.

Authors:  Timothy Lawn; Yahyah Aman; Katarina Rukavina; George Sideris-Lampretsas; Matthew Howard; Clive Ballard; Kallol Ray Chaudhuri; Marzia Malcangio
Journal:  Pain       Date:  2021-04-01       Impact factor: 7.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.